Karin Conde-Knape
executiveFemale0.0Global Dominance: 0.00%
Karin Conde-Knape is the vice president of Novo Nordisk, the pharmaceutical company behind Wegovy and Ozempic, and she has spoken out about the challenges patients face in maintaining weight loss after discontinuing these medications. Her work focuses on the need for effective long-term solutions in obesity treatment and the physiological limits of current therapies.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Karin Conde-Knape is the vice president of Novo Nordisk, the manufacturer of Wegovy and Ozempic.
Emagrecer rápido, recuperar depois? O dilema do Ozempic. Veja em quanto tempo as pessoas engordam quando param de tomar o remédioO Globo·
Brazil· 2025-08-03
Brazil· 2025-08-03
Karin Conde-Knape is the vice president of Novo Nordisk and explains the challenges of maintaining weight loss after stopping medication.
Emagrecer rápido, recuperar depois? O dilema do Ozempic. Veja em quanto tempo as pessoas engordam quando param de tomar o remédioO Globo·Brazil· 2025-08-03
Brazil· 2025-08-03